Table: Modalis Therapeutics -Q1 group results

Modalis Therapeutics

06/05/2021 07:00

May 6 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2021        Mar 31, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               0 mln              13 mln                     
                   (-95.4 pct)                                      
  Operating       loss 252 mln        loss 116 mln                  
  Recurring       loss 245 mln        loss 116 mln                  
  Net                201 mln          loss 118 mln                  
  EPS               7.07 yen          loss 4.71 yen                 
  EPS Diluted       6.66 yen                                        
  Ann Div                                  NIL              NIL     
  -Q2 div                                  NIL              NIL     
  -Q4 div                                  NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T